Nurix Therapeutics, Inc. NRIX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s total current liabilities?
- Nurix Therapeutics, Inc. (NRIX) reported total current liabilities of $92.2M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Nurix Therapeutics, Inc.'s total current liabilities increased by 2.5% year-over-year, from $89.99M to $92.2M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s total current liabilities has grown at a 14.2% compound annual growth rate (CAGR), from $44.54M to $86.47M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.